Background: Thiopurines are considered immunosuppressive agents and may be associated with an increased risk for infections. However, few inflammatory bowel disease (IBD) patients are appropriately vaccinated, and data on their ability to mount an immune response are vague. We evaluated the effects
Response to hepatitis A vaccine in children with inflammatory bowel disease receiving infliximab
β Scribed by Jonathan Moses; Naim Alkhouri; Angela Shannon; Ariel Feldstein; Christine Carter-Kent
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 35 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: There are only a few studies on immune response to routine vaccinations in children with inflammatory bowel disease (IBD), despite a strong need for this kind of study. The aim of the study was to evaluate the immunogenicity of an inactivated hepatitis A vaccine (HAV) in IBD pediatric pa
Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu
## Background: Crohn's disease and ulcerative colitis, referred to as inflammatory bowel diseases, affect mainly young adults and have an elevated morbidity and a negative effect on quality of life. this study aimed to compare the health-related quality of life between 2 randomized groups of patien
## Background: Noninvasive, sensitive, and specific tools for early identification of chronic inflammatory bowel disease (ibd) are needed for clinical practice. the aim was to identify new noninvasive test combinations for characterization of ibd in children and adolescents by comparing serological
Hepatitis B (HB) vaccine provides an uncertain duration of protection and the optimal timing of booster vaccine remains unclear. This study examined the immune response at 10 years of 118 children who had developed protective anti-HB surface (anti-HBs) levels after a primary series of HB immunizatio